本页面由Tiger Trade Technology Pte. Ltd.提供服务

Hims & Hers Health Inc.

27.73
-1.8100-6.13%
成交量:882.65万
成交额:2.49亿
市值:64.70亿
市盈率:-44.51
高:29.62
开:29.20
低:27.49
收:29.54
52周最高:65.30
52周最低:13.74
股本:2.33亿
流通股本:2.14亿
量比:1.72
换手率:4.13%
股息:- -
股息率:- -
每股收益(TTM):-0.6230
每股收益(LYR):0.5123
净资产收益率:-32.03%
总资产收益率:-2.21%
市净率:19.96
市盈率(LYR):54.13

数据加载中...

2026/10/07

重要事件披露

Form 8-K - Current report
2026/10/01

关联方拟减持公告

Form 144 | Hims & Hers Health, Inc. 高管 Okupe Oluyemi 拟减持2000股Class A股票,总市值约59400美元
2026/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144|Hims & Hers Health, Inc. 高管 Soleil Boughton 拟减持3458股,总市值约9.80万美元
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 | Hims & Hers Health, Inc. 高管兼董事 Autor Deborah M. 拟减持16773股Class A,总价约46.71万美元
2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/22

关联方拟减持公告

Form 144 | Hims & Hers Health 前董事 Pendarvis Christiane 拟减持3500股,总价约11.33万美元
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/06

关联方拟减持公告

Form 144 | Hims & Hers Health 高管 Oluyemi Okupe 拟减持28,652股,拟套现约1,096,798.56美元
2026/07/01

重要事件披露

Form 8-K - Current report
2026/06/18

关联方拟减持公告

Form 144 | Hims & Hers Health, Inc.高管Carroll Patrick Harrison拟减持23726股,总价约83万美元